Axxcess Wealth Management LLC Acquires 267 Shares of JPMorgan Chase & Co. (NYSE:JPM)

Axxcess Wealth Management LLC raised its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 0.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 147,558 shares of the financial services provider’s stock after buying an additional 267 shares during the period. JPMorgan Chase & Co. comprises about 0.8% of Axxcess Wealth Management LLC’s holdings, making the stock its 24th largest position. Axxcess Wealth Management LLC’s holdings in JPMorgan Chase & Co. were worth $35,371,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Midwest Capital Advisors LLC purchased a new stake in JPMorgan Chase & Co. in the 4th quarter valued at $43,000. Legacy Investment Solutions LLC purchased a new position in JPMorgan Chase & Co. during the 3rd quarter worth $45,000. Collier Financial bought a new stake in shares of JPMorgan Chase & Co. in the 4th quarter worth $45,000. Lowe Wealth Advisors LLC raised its holdings in shares of JPMorgan Chase & Co. by 34.0% in the fourth quarter. Lowe Wealth Advisors LLC now owns 201 shares of the financial services provider’s stock valued at $48,000 after purchasing an additional 51 shares during the last quarter. Finally, Kieckhefer Group LLC bought a new position in shares of JPMorgan Chase & Co. during the fourth quarter valued at about $50,000. 71.55% of the stock is currently owned by institutional investors and hedge funds.

JPMorgan Chase & Co. Trading Up 1.2 %

NYSE:JPM opened at $250.99 on Wednesday. JPMorgan Chase & Co. has a 1 year low of $179.20 and a 1 year high of $280.25. The stock’s fifty day moving average price is $258.02 and its two-hundred day moving average price is $239.98. The company has a debt-to-equity ratio of 1.24, a current ratio of 0.88 and a quick ratio of 0.89. The company has a market cap of $701.79 billion, a P/E ratio of 12.71, a P/E/G ratio of 2.83 and a beta of 1.10.

JPMorgan Chase & Co. (NYSE:JPM) last issued its quarterly earnings data on Wednesday, January 15th. The financial services provider reported $4.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.03 by $0.78. The business had revenue of $42.77 billion for the quarter, compared to analysts’ expectations of $41.90 billion. JPMorgan Chase & Co. had a return on equity of 16.99% and a net margin of 20.96%. The firm’s quarterly revenue was up 10.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.04 EPS. As a group, analysts expect that JPMorgan Chase & Co. will post 18.1 EPS for the current year.

JPMorgan Chase & Co. Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Friday, April 4th will be paid a dividend of $1.40 per share. The ex-dividend date of this dividend is Friday, April 4th. This represents a $5.60 annualized dividend and a yield of 2.23%. This is a boost from JPMorgan Chase & Co.’s previous quarterly dividend of $1.25. JPMorgan Chase & Co.’s payout ratio is currently 28.37%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on JPM shares. Barclays upped their price objective on shares of JPMorgan Chase & Co. from $304.00 to $330.00 and gave the stock an “overweight” rating in a research report on Thursday, January 16th. Bank of America increased their price target on JPMorgan Chase & Co. from $260.00 to $280.00 and gave the company a “buy” rating in a research report on Tuesday, January 7th. Piper Sandler boosted their price objective on JPMorgan Chase & Co. from $240.00 to $275.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 3rd. Wolfe Research upgraded JPMorgan Chase & Co. from a “peer perform” rating to an “outperform” rating and set a $269.00 price objective for the company in a research note on Friday, January 3rd. Finally, Truist Financial lifted their target price on JPMorgan Chase & Co. from $260.00 to $268.00 and gave the stock a “hold” rating in a research note on Thursday, January 16th. Ten analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $252.89.

Insider Activity at JPMorgan Chase & Co.

In related news, insider Robin Leopold sold 1,250 shares of the business’s stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $246.92, for a total transaction of $308,650.00. Following the completion of the transaction, the insider now directly owns 49,127 shares in the company, valued at $12,130,438.84. The trade was a 2.48 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Troy L. Rohrbaugh sold 37,500 shares of the firm’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $269.84, for a total value of $10,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 158,381 shares in the company, valued at approximately $42,737,529.04. The trade was a 19.14 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 76,848 shares of company stock valued at $19,987,908. Corporate insiders own 0.79% of the company’s stock.

About JPMorgan Chase & Co.

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.